Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer

Peking University First Hospital, Beijing

Beijing Cancer Hospital, Beijing

Peking Union Medical College Hospital, Beijing

Liaoning Cancer Hospital and Institute, Shenyang

The Second Hospital of Dalian Medical University, Dalian

Jilin Cancer Hospital, Changchun

The First Hospital of Jilin University, Changchun

Harbin Medical University Cancer Hospital, Harbin

Obstetrics and Gynecology Hospital of Fudan University, Shanghai

Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital, Hefei

Qilu Hospital of Shandong University, Jinan

Yantai Yuhuangding Hospital, Yantai

Tianjin Central Hospital of Gynecology Obstetrics, Tianjin

Tianjin Medical University Cancer Institute and Hospital, Tianjin

Zhejiang Cancer Hospital, Hangzhou

Jiangxi Maternal and Child Health Hospital, Nanchang

Chongqing Cancer Hospital, Chongqing

Southwest Hospital, Chongqing

Hunan Cancer Hospital, Changsha

Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan

Hubei Cancer Hospital, Wuhan

Henan Cancer Hospital, Zhengzhou

Sun Yat Sen Memorial Hospital, Sun Yat Sen University (North), Guangzhou

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

Cancer Hospital of Shantou University Medical College, Shantou

The Tumor Hospital Affiliated to Guangxi Medical University, Nanning

West China Second University Hospital, Chengdu